Works matching DE "CYCLIN-dependent kinase inhibitors"

Results: 1250

A Vitiligo-like Cutaneous Reaction Induced by Ribociclib in Advanced Breast Cancer: An Unusual Case Report from Colombia.

Published in:

Diseases, 2025, v. 13, n. 5, p. 158, doi. 10.3390/diseases13050158

By:

Montenegro, John Fernando;
Rivas-Tafurt, Giovanna Patricia;
Vidal-Cañas, Sinthia;
Diaz-Diaz, Miguel Ángel;
Bermudez, Cesar Eduardo;
Florez, Daniel;
Bravo-Gustin, Andres Felipe;
Liscano, Yamil

Publication type:

Article

Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Radiotherapy in Curative Breast Cancer Patients Induced Pneumonitis: A Case Report.

Published in:

Life (2075-1729), 2025, v. 15, n. 5, p. 709, doi. 10.3390/life15050709

By:

Hou, Pei-Yu

Publication type:

Article

Allelic expression imbalance of CDKN2A variants in childhood acute lymphoblastic leukemia.

Published in:

Cellular Oncology (2211-3428), 2025, v. 48, n. 3, p. 835, doi. 10.1007/s13402-025-01049-6

By:

Tang, Zhexuan;
Pei, Kunlin;
Xu, Haoyu;
Zheng, Yongzhi;
Zhuang, Shuquan;
Weng, Kaizhi;
He, Yingyi;
Wu, Jing;
Zhang, Hui

Publication type:

Article

mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders.

Published in:

Veterinary & Comparative Oncology, 2022, v. 20, n. 3, p. 587, doi. 10.1111/vco.12812

By:

Hirabayashi, Miyuki;
Chambers, James K.;
Tani, Akiyoshi;
Tomiyasu, Hirotaka;
Motegi, Tomoki;
Rimpo, Kenji;
Nakayama, Hiroyuki;
Uchida, Kazuyuki

Publication type:

Article

In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD‐0332991) for treating canine mammary tumours.

Published in:

Veterinary & Comparative Oncology, 2019, v. 17, n. 4, p. 507, doi. 10.1111/vco.12514

By:

Schoos, Alexandra;
Knab, Vanessa M.;
Gabriel, Cordula;
Tripolt, Sabrina;
Wagner, Daniela A.;
Bauder, Barbara;
Url, Angelika;
Fux, Daniela A.

Publication type:

Article

Investigation of the cytotoxic effect of flavopiridol in canine lymphoma cell lines.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, p. 95, doi. 10.1111/vco.12130

By:

Ema, Y.;
Igase, M.;
Takeda, Y.;
Yanase, T.;
Umeki, S.;
Hiraoka, H.;
Okuda, M.;
Mizuno, T.

Publication type:

Article

Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo.

Published in:

Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09423-7

By:

Li, Ruichen;
Wang, Qi;
Zhao, Yang;
Zhu, Yi;
Wang, Xiaoshen

Publication type:

Article

The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast.

Published in:

Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-023-09119-4

By:

Pandithar, Sneha;
Galke, Daniel;
Akume, Ahone;
Belyakov, Artem;
Lomonaco, Dominick;
Guerra, Amirah A.;
Park, Jay;
Reff, Olivia;
Jin, Kideok

Publication type:

Article

CDK11 kinase activity is required to protect sister chromatid cohesion at centromeres in mitosis.

Published in:

Chromosome Research, 2014, v. 22, n. 3, p. 267, doi. 10.1007/s10577-013-9400-x

By:

Rakkaa, Tarik;
Escudé, Christophe;
Giet, Régis;
Magnaghi-Jaulin, Laura;
Jaulin, Christian

Publication type:

Article

Analyzing the scaffold diversity of cyclin‐dependent kinase inhibitors and revisiting the clinical and preclinical pipeline.

Published in:

Medicinal Research Reviews, 2022, v. 42, n. 2, p. 654, doi. 10.1002/med.21856

By:

Bhurta, Deendyal;
Bharate, Sandip B.

Publication type:

Article

Real-world experience with CDK4/6 inhibitors in hormone receptor-positive metastatic and recurrent breast cancer: findings from an Asian population.

Published in:

Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01458-1

By:

Chen, Bo-Fang;
Tsai, Yi-Fang;
Chao, Ta-Chung;
Lien, Pei-Ju;
Lin, Yen-Shu;
Feng, Chin-Jung;
Chen, Yen-Jen;
Cheng, Han-Fang;
Liu, Chun-Yu;
Lai, Jiun-I;
Tseng, Ling-Ming;
Huang, Chi-Cheng

Publication type:

Article

Clinical and Genomic Analysis of Patients with Short Survival after Surgery for Esophageal Squamous Cell Carcinoma.

Published in:

Digestive Diseases, 2023, v. 41, n. 3, p. 353, doi. 10.1159/000527983

By:

Gao, Lu;
Guo, Rong-Yun;
Lu, Hao;
Shi, Zhi-Hua;
Liu, Jun-Feng

Publication type:

Article

MicroRNA-93 Targets p21 and Promotes Proliferation in Mycosis Fungoides T Cells.

Published in:

Dermatology (10188665), 2021, v. 237, n. 2, p. 277, doi. 10.1159/000505743

By:

Gluud, Maria;
Fredholm, Simon;
Blümel, Edda;
Willerslev-Olsen, Andreas;
Buus, Terkild Brink;
Nastasi, Claudia;
Krejsgaard, Thorbjørn;
Bonefeld, Charlotte Menné;
Woetmann, Anders;
Iversen, Lars;
Litman, Thomas;
Geisler, Carsten;
Ødum, Niels;
Lindahl, Lise M.

Publication type:

Article

Evaluation of Cyclin-Dependent Kinase Inhibitor 2A and Hepatocyte Nuclear Factor-1A Gene Polymorphisms in Coronary Artery Diseases.

Published in:

Zagazig University Medical Journal, 2024, v. 30, n. 3, p. 859, doi. 10.21608/ZUMJ.2022.161460.2636

By:

Ibrahimm, Magdy;
Sherif, Abdelsalam;
Mohamed, Dina Salah;
Samy, Walaa

Publication type:

Article

Precision diagnosis and treatment of breast cancer in the post-CDK4/6 inhibitor era.

Published in:

China Oncology, 2025, v. 35, n. 3, p. 273, doi. 10.19401/j.cnki.1007-3639.2025.03.003

By:

LI Bin;
TAO Zhonghua;
HU Xichun

Publication type:

Article

"Subtype-precise" therapy leads diagnostic and therapeutic innovations: a new pattern for precision treatment of breast cancer.

Published in:

China Oncology, 2024, v. 34, n. 11, p. 1045, doi. 10.19401/j.cnki.1007-3639.2024.11.007

By:

ZHANG Siwei;
MA Ding;
JIANG Yizhou;
SHAO Zhimin

Publication type:

Article

Decreased mitochondrial transcription factor A and mitochondrial DNA copy number promote cyclin-dependent kinase inhibitor 1A expression and reduce tumorigenic properties of colorectal cancer cells.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01538-4

By:

Buchwaldt, Jessika;
Fritsch, Tania;
Hartmann, Monika;
Witzel, Hagen Roland;
Kloth, Michael;
Roth, Wilfried;
Tagscherer, Katrin E.;
Hartmann, Nils

Publication type:

Article

Prognostic significance of systemic immune inflammation indices and prognostic nutritional index before CDK4/6 inhibitor therapy in hormone receptor positive, HER2 negative metastatic breast cancer patients.

Published in:

Pamukkale Medical Journal, 2023, v. 16, n. 4, p. 682, doi. 10.31362/patd.1268419

By:

Demirel, Burçin Çakan;
Yaren, Arzu;
Demiray, Atike Gökçen;
Taşköylü, Burcu Yapar;
Doğan, Tolga;
Özdemir, Melek;
Kantar, Taliha Güçlü;
Karan, Canan;
Değirmencioğlu, Serkan;
Doğu, Gamze Gököz

Publication type:

Article

From Roscovitine to CYC202 to Seliciclib -- from bench to bedside: discovery and development.

Published in:

BioDiscovery, 2017, p. 1, doi. 10.7750/BioDiscovery.2013.10.1

By:

Zhelev, Nikolai;
Trifonov, Dimitar;
Shudong Wang;
Hassan, Moustapha;
El Serafi, Ibrahim;
Mitev, Vanio

Publication type:

Article

Modelling c-Abl Signalling in Activated Neutrophils: the Anti-inflammatory Effect of Seliciclib.

Published in:

BioDiscovery, 2017, p. 1, doi. 10.7750/BioDiscovery.2013.7.4

By:

Jackson, Robert C.;
Radivoyevitch, Tomas

Publication type:

Article

A Sensitive, Green, and Fast LC–MS/MS Analytical Method for the Quantification of Ribociclib: Evaluation of the Metabolic Stability in HLMs.

Published in:

Separations (2297-8739), 2023, v. 10, n. 9, p. 472, doi. 10.3390/separations10090472

By:

Attwa, Mohamed W.;
Abdelhameed, Ali S.;
Kadi, Adnan A.

Publication type:

Article

Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma.

Published in:

NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00653-3

By:

Freitag, Thomas;
Kaps, Philipp;
Ramtke, Justus;
Bertels, Sarah;
Zunke, Emily;
Schneider, Björn;
Becker, Anne-Sophie;
Koczan, Dirk;
Dubinski, Daniel;
Freiman, Thomas M.;
Wittig, Felix;
Hinz, Burkhard;
Westhoff, Mike-Andrew;
Strobel, Hannah;
Meiners, Franziska;
Wolter, Daniel;
Engel, Nadja;
Troschke-Meurer, Sascha;
Bergmann-Ewert, Wendy;
Staehlke, Susanne

Publication type:

Article

NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.

Published in:

NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00627-5

By:

Xu, Duo;
Yin, Shiyuan;
Shu, Yongqian

Publication type:

Article

Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib.

Published in:

NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00607-9

By:

de Jager, Vincent D.;
Stigt, Jos A.;
Niemantsverdriet, Maarten;
ter Elst, Arja;
van der Wekken, Anthonie J.

Publication type:

Article

Determinants of response to CDK4/6 inhibitors in the real-world setting.

Published in:

NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00438-0

By:

Witkiewicz, Agnieszka K.;
Schultz, Emily;
Wang, Jianxin;
Hamilton, Deanna;
Levine, Ellis;
O'Connor, Tracey;
Knudsen, Erik S.

Publication type:

Article

EXPLORING APOPTOTIC EFFECTS OF STENOENDEMIC ACINOS ORONTIUS PLANT EXTRACTS IN GR-M MELANOMA CELLS: INITIAL FINDINGS.

Published in:

Genetics & Applications, 2023, p. 66

By:

Lejla, Lasić;
Jasna, Hanjalić Kurtović;
Lejla, Ušanović;
Merima, Miralem;
Belma, Kalamujić Stroil;
Naris, Pojskić

Publication type:

Article

QTc prolongation across CDK4/6 inhibitors: a systematic review and meta-analysis of randomized controlled trials.

Published in:

JNCI Cancer Spectrum, 2024, v. 8, n. 5, p. 1, doi. 10.1093/jncics/pkae078

By:

Murad, Bruno;
Reis, Pedro C A;
Marinho, Alice Deberaldini;
Comini, Ana Carolina Marin;
Xavier, Débora Pinheiro;
Pessoa, Beatriz Mella Soares;
Raheem, Farah;
Ernst, Brenda;
Mina, Lida A;
Batalini, Felipe

Publication type:

Article

Double-Faced Immunological Effects of CDK4/6 Inhibitors on Cancer Treatment: Challenges and Perspectives.

Published in:

Bioengineering (Basel), 2024, v. 11, n. 11, p. 1084, doi. 10.3390/bioengineering11111084

By:

Liu, Yongqin;
Deng, Yiying;
Yang, Chang;
Naranmandura, Hua

Publication type:

Article

Network pharmacological approach combined with weighted gene co-expression network analysis identifies CDKN2A as the keg target of Changweiqing against colorectal cancer.

Published in:

Hereditas, 2025, v. 162, n. 1, p. 1, doi. 10.1186/s41065-025-00405-8

By:

Zushuai, Ma;
Yanrong, Ji;
Chengdu, Zhao;
Xu, Zhu;
Qianshan, Ding

Publication type:

Article

<italic>Mnb/Dyrk1A</italic> orchestrates a transcriptional network at the transition from self-renewing neurogenic progenitors to postmitotic neuronal precursors.

Published in:

Journal of Neurogenetics, 2018, v. 32, n. 1, p. 37, doi. 10.1080/01677063.2018.1438427

By:

Shaikh, Mirja N.;
Tejedor, Francisco J.

Publication type:

Article

CDK4/6 inhibition in cancer: the cell cycle splicing connection.

Published in:

2019

By:

Sheppard, Karen E.;
AbuHammad, Shatha

Publication type:

Opinion

The role of vitamin D up-regulated protein 1 in epithelial ovarian cancer.

Published in:

European Journal of Gynaecological Oncology, 2019, v. 40, n. 4, p. 585, doi. 10.12892/ejgo4484.2019

By:

Dong-Hee Kim;
Seung-Do Choi;
Hae-Hyeog Lee;
Tae-Hee Kim;
Yeon-Suk Kim;
Yesol Kim

Publication type:

Article

Expression of Jun activation domain-binding protein 1 and p27 Kip1 in endometrial polyps and uterine leiomyomas.

Published in:

European Journal of Gynaecological Oncology, 2018, v. 39, n. 4, p. 533, doi. 10.12892/ejgo3857.2018

By:

Lee, Arum;
Kim, Tae-Hee;
Lee, Hae-Hyeog;
Kim, Jun-Mo;
Kim, Yeon-Suk

Publication type:

Article

Loss of p27 expression in endometrial carcinoma patients with recurrent tumor is significantly associated with poor survival.

Published in:

European Journal of Gynaecological Oncology, 2018, v. 39, n. 1, p. 119, doi. 10.12892/ejgo3784.2018

By:

Al-Maghrabi, J.;
Abdelrahman, A. S.;
Al-Maghrabi, B.;
Buhmeida, A.;
Abuzenadah, A.;
Al-Qahtani, M.;
Al-Ahwal, M.;
Khabaz, M. N.

Publication type:

Article

毛喉素诱导猪卵泡颗粒细胞体外分化机制的研究.

Published in:

Journal of Nanjing Agricultural University / Nanjuing Nongye Daxue Xuebao, 2021, v. 44, n. 1, p. 160, doi. 10.7685/jnau.201912021

By:

于昊;
李曼曼;
薛洋;
姜志洋;
茆达干

Publication type:

Article

Functional Conservation in the SIAMESE-RELATED Family of Cyclin-Dependent Kinase Inhibitors in Land Plants.

Published in:

Plant Cell, 2015, v. 27, n. 11, p. 3065, doi. 10.1105/tpc.15.00489

By:

Kumar, Narender;
Harashima, Hirofumi;
Kalve, Shweta;
Bramsiepe, Jonathan;
Wang, Kai;
Sizani, Bulelani L.;
Bertrand, Laura L.;
Johnson, Matthew C.;
Faulk, Christopher;
Dale, Renee;
Simmons, L. Alice;
Churchman, Michelle L.;
Sugimoto, Keiko;
Kato, Naohiro;
Dassanayake, Maheshi;
Beemster, Gerrit;
Schnittger, Arp;
Larkin, John C.

Publication type:

Article

Cyclin-Dependent Kinase Inhibitor KRP6 Induces Mitosis and Impairs Cytokinesis in Giant Cells Induced by Plant-Parasitic Nematodes in Arabidopsis.

Published in:

Plant Cell, 2014, v. 26, n. 6, p. 2633, doi. 10.1105/tpc.114.126425

By:

Vieira, Paulo;
Clercq, Annelies De;
Stals, Hilde;
Leene, Jelle Van;
Slijke, Eveline Van De;
Isterdael, Gert Van;
Eeckhout, Dominique;
Persiau, Geert;
Damme, Daniël Van;
Verkest, Aurine;
Souza, José Dijair Antonino de;
Júnior;
Glab, Nathalie;
Abad, Pierre;
Engler, Gilbert;
Inzé, Dirk;
Veylder, Lieven De;
Jaeger, Geert De;
Engler, Janice de Almeida

Publication type:

Article

Arabidopsis SIAMESE-RELATED Cyclin-Dependent Kinase Inhibitors SMR5 and SMR7 Regulate the DNA Damage Checkpoint in Response to Reactive Oxygen Species.

Published in:

Plant Cell, 2014, v. 26, n. 1, p. 296, doi. 10.1105/tpc.113.118943

By:

Yi, Dalong;
Kamei, Claire Lessa Alvim;
Cools, Toon;
Vanderauwera, Sandy;
Takahashi, Naoki;
Okushima, Yoko;
Eekhout, Thomas;
Yoshiyama, Kaoru Okamoto;
Larkin, John;
Daele, Hilde Van den;
Conklin, Phillip;
Britt, Anne;
Umeda, Masaaki;
Veylder, Lieven De

Publication type:

Article

Middle-Aged Indians with Type 2 Diabetes Are at Higher Risk of Biological Ageing with Special Reference to Serum CDKN2A.

Published in:

Journal of Diabetes Research, 2020, p. 1, doi. 10.1155/2020/7569259

By:

Banerjee, Joyita;
Dhas, Yogita;
Mishra, Neetu

Publication type:

Article

Long‑term progression‑free survival in HR+/HER2+ advanced breast cancer with combination therapy with a CDK4/6 inhibitor and first‑line maintenance therapy: A case report.

Published in:

Oncology Letters, 2025, v. 29, n. 5, p. N.PAG, doi. 10.3892/ol.2025.14973

By:

Cai, Yihong;
Zhang, Jinling;
Duan, Hongxia;
Liu, Fan

Publication type:

Article

Utidelone combined with anti‑angiogenic therapy for the treatment of anthracycline/taxane‑treated and endocrine‑resistant HR+/HER2‑ refractory breast cancer with brain metastases: A case report.

Published in:

Oncology Letters, 2025, v. 29, n. 1, p. N.PAG, doi. 10.3892/ol.2024.14771

By:

Bai, Xue;
Liu, Meidi;
Chen, Xuelian;
Song, Lin;
Zhang, Jiaxian;
Song, Qing;
Xie, Xiaofeng;
Lan, Xiaofeng;
Chen, Liping;
Huang, Jiayi;
Du, Caiwen

Publication type:

Article

Synergistic effect of bazedoxifene and abemaciclib co‑treatment in triple‑negative breast cancer cells in vitro.

Published in:

Oncology Letters, 2024, v. 28, n. 6, p. N.PAG, doi. 10.3892/ol.2024.14688

By:

Caroland, Kailey;
Shi, Changyou;
Lin, Jiayuh

Publication type:

Article

Sodium valproate affects the expression of p16INK4a and p21WAFI/Cip1 cyclin‑dependent kinase inhibitors in HeLa cells.

Published in:

Oncology Letters, 2024, v. 28, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14563

By:

Rocha, Marina Amorim;
Cardoso, Adauto Lima;
Martins, Cesar;
Mello, Maria Luiza S.

Publication type:

Article

Recommendations for cyclin‑dependent kinase 4/6 inhibitor treatments in the context of co‑morbidity and drug interactions (Review).

Published in:

Oncology Letters, 2024, v. 27, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14278

By:

Teomete, Mehmet;
Cabuk, Devrim;
Korkmaz, Taner;
Seber, Selcuk;
Ozturk, Ozge Fulya;
Aver, Birkan;
Karaalp, Atila;
Basaran, Gul

Publication type:

Article

Liquid biopsy utilizing miRNA in patients with advanced breast cancer treated with cyclin‑dependent kinase 4/6 inhibitors.

Published in:

Oncology Letters, 2024, v. 27, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14314

By:

Kubeczko, Marcin;
Tudrej, Patrycja;
Tyszkiewicz, Tomasz;
Krzywon, Aleksandra;
Oczko-Wojciechowska, MaŁgorzata;
JarzĄb, MichaŁ

Publication type:

Article

Transcriptomic analysis of the effects of the HPV18 E6E7 gene on the cell death mode in esophageal squamous cell carcinoma.

Published in:

Oncology Letters, 2023, v. 25, n. 4, p. N.PAG, doi. 10.3892/ol.2023.13753

By:

Tang, Duo;
Wang, Guozhen;
Liu, Zijia;
Wang, Biqi;
Yao, Mengfei;
Wang, Qian;
Hou, Xiaonan;
Zheng, Yuchen;
Sheng, Chao;
Zhou, Zhixiang

Publication type:

Article

rs77283072 influences breast cancer susceptibility by regulating CDKN2A expression.

Published in:

Oncology Letters, 2023, v. 25, n. 2, p. N.PAG, doi. 10.3892/ol.2023.13662

By:

He, Guang-Huan;
Liu, Shao-Dong;
Shi, Xiao-Qian;
Chen, Ying;
Su, Li;
Shi, Qiao-Na;
Sun, Chang

Publication type:

Article

Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report.

Published in:

2022

By:

Yabuuchi, Yuki;
Hiroshima, Kenzo;
Oshima, Hisayuki;
Kanazawa, Jun;
Hayashihara, Kenji;
Nakagawa, Takayuki;
Shimanouchi, Masaki;
Usui, Shingo;
Oh-Ishi, Shuji;
Saito, Takefumi;
Hizawa, Nobuyuki;
Minami, Yuko

Publication type:

Case Study

Short 57 kb CDKN2A FISH probe effectively detects short homozygous deletion of the 9p21 locus in malignant pleural mesothelioma.

Published in:

2021

By:

Oyama, Yuzo;
Hamasaki, Makoto;
Matsumoto, Shinji;
Sato, Ayuko;
Tsujimura, Tohru;
Nabeshima, Kazuki

Publication type:

Case Study

Effects of hypoxia on DNA hydroxymethylase Tet methylcytosine dioxygenase 2 in a KG-1 human acute myeloid leukemia cell line and its mechanism.

Published in:

Oncology Letters, 2021, v. 22, n. 4, p. N.PAG, doi. 10.3892/ol.2021.12953

By:

He, Ping;
Lei, Jian;
Zou, Li-Xin;
Zhou, Gui-Zhen;
Peng, Lang;
Deng, Qian;
Liu, Xiao-Liu

Publication type:

Article